Novartis AG had a softer start to the year, missing on both earnings and revenue in Q1, even as it chose to stand by its full-year outloo ...

I rate EOG Resources a Buy with a $131 price target, based on 2026 EBITDA estimates and a 5.6x multiple at $70 oil. EOG's core and emerging assets, strong free cash flow, and shareholder returns ...

Have you ever looked at a company’s soaring “Net Income” and wondered why they were suddenly cutting their dividend or taking on new debt? It feels like looking at a beautifully painted car that ...

Build $2,400 in TFSA passive income using reliable Canadian dividend stocks that deliver steady, tax‑free cash flow for ...